Options: Hide MedDRA Preferred Terms , display all 37 labels
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cardiac failure | x | ||||||||||||||||||||||
| Cerebrovascular accident | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||||
| Cough | x | x | |||||||||||||||||||||
| Diabetic | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
| Diabetic nephropathy | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||||||
| Essential hypertension | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||
| Hypersensitivity | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
| Hypertension | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||
| Hypertensive | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||
| Left ventricular hypertrophy | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||
| Myocardial infarction | x | ||||||||||||||||||||||
| Nephropathy | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
| Proteinuria | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
| Renal failure chronic | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||||
| Type 2 diabetes mellitus | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||||||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |